Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations

Journal of Drug Targeting

Volumn 13, Issue 1, 2005, Pages 19-27

  Fang, Jia You ^a   Hung, Chi Feng ^b   Hwang, Tsong Long ^a   Huang, Yen Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

(+) catechin; ( ) epicatechin; ( ) epigallocatechin 3 gallate (EGCG); Liposomes; Skin; Tumor

Indexed keywords

CATECHIN; CHOLESTEROL; DEOXYCHOLIC ACID; DICETYL PHOSPHATE; EPICATECHIN; EPIGALLOCATECHIN GALLATE; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYPHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG UPTAKE; ENCAPSULATION; FEMALE; IN VIVO STUDY; LIPID BILAYER; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN ABSORPTION; SOLID TUMOR; TEA; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; ANIMALS; CATECHIN; DEOXYCHOLIC ACID; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; INJECTIONS, INTRALESIONAL; LIPOSOMES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHOSPHORIC ACID ESTERS; SKIN; SKIN NEOPLASMS; TEA;

EID: 14644440624     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400015977     Document Type: Article

References (30)

1. Allen, TM, Hansen CB, Lopes de Menezes DE. 1995. Pharmacokinetics of long-circulating liposomes, Adv Drug Deliv Rev 16:267-284.
2. Blache D, Durand P, Prost M, Loreau N. 2002. (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo Free Radic Biol Med 33:1670-1680.
3. Buszello K, Harnisch S, Müller RH, Müller BW. 2000. The influence of alkali fatty acids on the properties and the stability of parenteral o/w emulsions modified with Solutol HS15®, Eur J Pharm Biopharm 49:143-149.
4. Cai Y, Anavy ND, Chow HS. 2002. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats, Drug Metab Dispos 30:1246-1249.
5. 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat, Xenobiotica 33:743-753.
6. Chen L, Lee MJ, Li H, Yang CS. 1997. Absorption, distribution, and elimination of tea polyphenols in rats, Drug Metab Dispos 25:1045-1050.
7. du Plessis J, Ramachandran C, Weiner N, Müller DG. 1994. The influence of particle size of liposomes on the deposition of drug into skin, Int J Pharm 103:277-282.
8. Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS. 1999. Pharmacokinetics of the green tea derivatives, EGCG, by the topical route of administration in mouse and human skin, Cancer Chemother Pharmacol 43:331-335.
9. Fang JY, Lin HH, Hsu LR, Tsai YH. 1997. Characterization and stability of various liposome-encapsulated enoxacin formulations, Chem Pharm Bull 45:1504-1509.
10. Gabizon AA. 2002. Liposomal drug carrier systems in cancer chemotherapy: current status and future prospects, J Drug Target 10:535-538.
11. Gregoriadis G. 1976. The carrier potential of liposomes in biology and medicine, New Engl J Med 295:704-710.
12. Harashima H, Tsuchihashi M, Iida S, Doi H, Kiwada H. 1999. Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes, Adv Drug Deliv Rev 40:39-61.
13. Hashimoto T, Kumazawa S, Nanjo F, Hara Y, Nakayama T. 1999. Interaction of tea catechins with lipid bilayers investigated with liposome systems, Biosci Biotechnol Biochem 63:2252-2255.
14. Hazemoto N, Harada M, Suzuki S, Kaiho F, Haga M, Kato Y. 1993. Effect of phosphatidylcholine and cholesterol on pH-sensitive liposomes, Chem Pharm Bull 41:1003-1006.
15. Jain RK. 1989. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies, J Natl Cancer Inst 81:570-576.
16. Katiyar SK, Ahmad N, Mukhtar H. 2000. Green tea and skin, Arch Dermatol 136:989-994.
17. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. 1999. Liposome-skin interactions and their effects on the skin permeation of drugs, Eur J Pharm Sci 7:279-286.
18. Levin C, Maibach HI. 2002. Exploration of alternative and natural drugs in dermatology, Arch Dermatol 138: 207-211.
19. 1-containing liposomes, Biochim Biophys Acta 1104:95-101.
20. Mizuguchi H, Nakanishi T, Nakanishi M, Nakagawa T, Nakagawa S, Mayumi T. 1996. Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth, Cancer Lett 100:63-69.
21. Nagayasu A. Uchiyama K, Kiwada H. 1999. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs, Adv Drug Deliv Rev 40:75-87.
22. Ogiso T, Niinaka N, Iwaki M, Tanino T. 1997. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. Part II, Int J Pharm 152:135-144.
23. Oku N. 1999. Anticancer therapy using glucuronate modified long-circulating liposomes, Adv Drug Deliv Rev 40:63-73.
24. Uchiyama K, Nagayasu A, Yamagiwa Y, Nishida T, Harashima H, Kiwada H. 1995. Effects of the size and fluidity of liposomes on their accumulation in tumors: a presumption of their interaction with tumor, Int J Pharm 121:195-203.
25. Valenta C, Janisch M. 2003. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids, Int J Pharm 258:133-139.
26. Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin, Int J Pharm 258:141-151.
27. Yamaguchi T. 1996. Lipid microspheres as drug carriers: a pharmaceutical point of view, Adv Drug Deliv Rev 20:117-130.
28. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. 2001. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study, Lancet 357:426-929.
29. Yokomizo Y. 1996. Effect of phosphatidylcholine on the percutaneous penetration of drugs through the dorsal skin of guinea pigs in vitro and analysis of the molecular mechanism using ATR-FTIR spectroscopy, J Control Release 42:249-262.
30. Zhu QY, Holt RR, Lazarus SA, Ensunsa JL, Hammerstone JF, Schmitz HH, Keen CL. 2002. Stability of the flavan-3-ols epicatechin and catechin and relared dimeric procyanidins derived from cocoa, J Agric Food Chem 50:1700-1705.